Vanessa Haynes–Williams

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Christopher Koh, Laëtitia Canini, Harel Dahari et al. · The Lancet Infectious Diseases · 2015 · 263 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Long-term therapy of chronic delta hepatitis with peginterferon alfa

Theo Heller, Yaron Rotman, Christopher Koh et al. · Alimentary Pharmacology & Therapeutics · 2014 · 117 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling

Jordan J. Feld, Glen Lutchman, Theo Heller et al. · Gastroenterology · 2010 · 103 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +12

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype

Marc G. Ghany, Robert Perrillo, Ruosha Li et al. · Clinical Gastroenterology and Hepatology · 2014 · 96 citations · Full text

Medicine, Health Sciences, Infectious Diseases +9

The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes

Rohit Loomba, María M. Rivera, Robert P. McBurney et al. · Alimentary Pharmacology & Therapeutics · 2010 · 83 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +13